Evidence map›Paper›PMID 24238845›Full record

ArticleAnnals of diagnostic pathology2014

Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma.

Diana Bell, Ehab Y Hanna, Lucio Miele, Dianna Roberts, Randal S Weber, Adel K El-Naggar

Open access · greenAbstract read
In one paragraph

Article in Annals of diagnostic pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Notch signaling in oral pre-cancer and oral cancer.Medical oncology (Northwood, London, England) · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Head and Neck Carcinoma Immunotherapy: Facts and Hopes.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Review
  13. Article
  14. Article
  15. Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2017
    Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Diana BellDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: diana.bell@mdanderson.org.
Ehab Y Hanna
Lucio Miele
Dianna Roberts
Randal S Weber
Adel K El-Naggar
The University of Texas MD Anderson Cancer Center · USUniversity of Mississippi Medical Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Molecular and Epidemiologic Characterization of Salivary Gland CarcinomasU01DE019765 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI EL-NAGGAR, ADEL K. · 2009 to 2013
$6.9M
NCI NIH HHS P30 CA016672NIDCR NIH HHS U01 DE019765NIDCR NIH HHS UO1DE019765
6 · The paper itself

Abstract

Notch signaling plays a role in stem cell biology, tumor formation, angiogenesis, and cell death. Targeting Notch pathway could serve as a therapeutic strategy in cancer. Little is known about the differential role of various components of the Notch pathway in salivary adenoid cystic carcinoma (AdCC). To investigate the association of the Notch pathway in AdCC carcinogenesis, we analyzed the Notch receptor (Notch-1, Notch-2, Notch-4) and Notch ligand (Jagged-1, Delta) expressions. The results showed elevated expression levels of all 5 proteins in AdCC tissue relative to normal salivary gland tissues. Jagged-1/Notch-2 coexpression was significantly associated with increased patient survival rate. The elevated expression level of these Notch receptors and ligands in AdCC points to Notch signaling as a key player in AdCC pathogenesis. Our data provide evidence for a relationship between Jagged-1/Notch-2 coexpression and better overall patient survival with AdCC. Targeting Notch signaling pathway may provide therapeutic benefits for these patients.

Indexed as

Signal TransductionAdolescentAdultAgedAged, 80 and overBiomarkers, TumorCalcium-Binding ProteinsCarcinoma, Adenoid CysticFemaleHumansImmunohistochemistryIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsJagged-1 ProteinKaplan-Meier EstimateMaleBiomarkers, TumorCalcium-Binding Proteinsdelta proteinIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsJAG1 protein, humanJagged-1 ProteinMembrane ProteinsReceptors, NotchSerrate-Jagged ProteinsAdCCAdenoid cysticadenoid cystic carcinomacancer stem cellsCancer stem cellsCarcinomaCSCNotchNotch-2/Jagged-1Targeted therapy

Identifiers

PMID24238845
PMCPMC4807115
OpenAlexW2109285146

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.